Patient and Physician Behavior
Our work in Patient and Physician Behavior
-
Mortality and Morbidity in Ageing Men: Biology, Lifestyle and Environment
Males live shorter lives than women in all countries. The universality of shorter male life expectancy is a 21st Century phenomena. It occurs with the decline in infectious diseases and the rise in cardiovascular diseases accounting for mortality.
Categorized in -
A Cost-Utility Analysis of Remote Pulse-Oximetry Monitoring of Patients With COVID-19
Since 2020, COVID-19 has infected tens of millions and caused hundreds of thousands of fatalities in the United States. Infection waves lead to increased emergency department utilization and critical care admission for patients with respiratory distress. Although many individuals develop symptoms necessitating a ventilator, some patients with COVID-19 can remain at home to mitigate hospital overcrowding. Remote pulse-oximetry (pulse-ox) monitoring of moderately ill patients with COVID-19 can be used to monitor symptom escalation and trigger hospital visits, as needed.
Categorized in -
Electronic ‘Nudges’ May Improve Safety in Opioid Prescribing Among California Doctors, Study Finds
Researchers observed a 23% drop in opioid prescriptions and a 27% increase in prescriptions for naloxone.
Categorized in -
The Eldercare Facility Ordinance of Los Angeles: A Synthetic Control Analysis of Residential Care Development and Growth
Using California State Department of Social Services residential care and census place data, this study compares the pre and post effect of the ordinance on the number of large residential care facilities developed in Los Angeles with a comparison group using synthetic control analysis.
Categorized in -
Here’s How Public Health Messaging Can Help With the Next Phase of the Pandemic
As COVID-19 cases increase and officials warn of a potential new surge, confusion still bedevils our public health messaging.
Categorized in -
Use of Prescription Medications with Cardiovascular Adverse Effects Among Older Adults in the United States
Schaeffer experts examined the association between the concurrent use of prescription medications with known risk of a major adverse cardiovascular event (MACE) (“MACE medications”) and the risk of such events among older adults.
Categorized in -
Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health Record to Encourage Compliance With California State Opioid Law
A new study by experts at the USC Schaeffer Center for Health Policy and Economics and Kaiser Permanente finds Naloxone prescriptions increased while opioid prescriptions decreased.
Categorized in -
Racial Disparities in Accessing Treatment for Substance Use Highlights Work to Be Done
Older Americans are increasingly seeking treatment for substance use disorders with older Black Americans who start treatment being much more likely to have their treatment terminated and not finish compared to white adults.
Categorized in -
Biomedical Expert Designs Health Dataset Representing All Demographic Groups
Although big data is revolutionizing healthcare, its potential has been limited by underrepresentation of vulnerable populations, including marginalized racial and socioeconomic groups that are at higher risk for poor health outcomes.
Categorized in -
Impact of Cannabis Legalization on Healthcare Utilization for Psychosis and Schizophrenia in Colorado
Using administrative data from Colorado Hospital Association (CHA) on county-level quarterly ED visits between January 1, 2013, and December 31, 2018, Schaeffer experts applied a difference-in-difference analysis to examine how new exposure to recreational cannabis dispensaries after 2014 differentially influenced the rate of ED visits for psychosis and schizophrenia, comparing counties with no prior medical cannabis dispensary exposure to counties with low or high medical dispensary exposure.
Categorized in